Literature DB >> 23521818

Sinus involvement in breast cancer: case report.

D T Walker1, S Barbur, R Mathew, J Hern.   

Abstract

OBJECTIVE: To report a rare and unique presentation of metastatic breast cancer.
METHOD: Case report and review of related literature.
RESULTS: A 62-year-old female with metastatic breast cancer, who had been free from recurrence for 4 years, presented with diplopia secondary to lateral rectus palsy. This was due to a sphenoid sinus metastasis, which was eroding into her cavernous sinus, resulting in VIth cranial nerve neuropathy.
CONCLUSION: All paranasal sinuses and the orbit are potential sites for metastases. Spread to the paranasal sinuses from breast cancer has been documented previously. However, we believe this to be the only reported case with lateral rectus palsy as a result of metastasis to the sphenoid sinus in which this was the only evidence of disseminated disease. Otolaryngology clinicians need to consider metastatic disease to the sinuses in patients with a history of neoplasia, but also recognise that tamoxifen treatment can itself cause visual disturbance.

Entities:  

Mesh:

Year:  2013        PMID: 23521818     DOI: 10.1017/S002221511300039X

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

Review 1.  Paranasal sinus and retro-orbital metastasis in a case of breast carcinoma: a clinicoradiological review.

Authors:  Vivek Tiwari; Subodh Chandra Pande; Kamal Verma; Sandeep Goel
Journal:  BMJ Case Rep       Date:  2014-04-17

2.  Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review.

Authors:  Jie Xiong; Jing Chen; Liduan Zheng; Shengli Yang; Guifang Zhao; Jing Cheng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 3.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.